logo
Key Biden agency dropped $60K on overseas conference with DEI workshop: 'Should never happen'

Key Biden agency dropped $60K on overseas conference with DEI workshop: 'Should never happen'

Fox News14-05-2025

FIRST ON FOX: A government watchdog has uncovered that former President Joe Biden's Food and Drug Administration (FDA) spent tens of thousands of taxpayer dollars sending top officials to a conference in Scotland that included diversity, equity and inclusion (DEI) workshops.
The Functional Government Initiative (FGI), via a FOIA request, discovered that the Biden FDA spent an estimated $60,000 on a dozen staffers, including Senior Advisor for Health Equity Dr. Charlene Le Fauve, to attend the Society for Research on Nicotine and Tobacco's (SRNT's) conference in Edinburgh, Scotland, in March 2024.
While at the conference, members of the team attended a workshop that focused on the "stigma" facing LGBTQ+ people in the field of tobacco research.
Topics included in that workshop, according to the FDA's own report on the trip, included "how anti-LGBTQ+ legislation and discriminatory and stigmatizing environments toward LGBTQ+ populations impact tobacco use and tobacco control research" and "process to develop a community-based participatory research project to address smoking cessation among transgender individuals in Argentina."
Another topic discussed was "the challenges of conducting research on tobacco use in the high-stigma environment of pregnancy in a post-Dobbs era."
Le Fauve justified the trip, in part, by claiming "the knowledge gained at the meeting is critical to attendees' ability to understand emerging scientific issues that may impact their work and their ability to effectively move forward agency initiatives."
"The formal SRNT conference included many sessions where health equity was an identified focus and I attended several which were highly relevant, well done, and informative including the Presidential Symposium that included three presenters supporting the premise that in order to have a global impact on the tobacco smoking pandemic, nicotine and tobacco research must broaden its vision beyond wealthy countries to include research and researchers in low and middle-income countries (LMICs), where the vast majority of the world's people who smoke live," Le Fauve added.
Also present on the trip was Center for Tobacco Products Director Brian King, who was recently relieved of his duty by the Trump administration in a move that a former agency official told Fox News Digital was a result of the FDA straying from its core mission under the Biden administration and focusing on issues like DEI.
"There were many, many failures in the key core missions for the center that needed dramatic change in new leadership," David Oliveira, who recently left the FDA after six years, told Fox News Digital last month, explaining that the FDA was ceding responsibility to other departments and not doing enough to crackdown on China flooding the market with illicit vapes.
FGI Communications Director Roderick Law told Fox News Digital in a statement that spending tens of thousands of dollars to send a dozen employees to a conference in Scotland is another example of the agency losing focus on its mission.
"I, like anyone else in the world, would love to have a $60,000 vacation paid for by my employer," Law said.
"Sadly, this dream became reality for 12 people on the taxpayer's back. How can a group of government officials spend $60,000 on an LGBTQ+ workshop? How is it possible that this trip helped the agency stop illegal Chinese-made products or process applications for new products that could provide for harm reduction? This kind of waste should never happen again."
Fox News Digital reached out to the FDA for comment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Poland cancels acquisition process for 32 Black Hawk helicopters
Poland cancels acquisition process for 32 Black Hawk helicopters

Yahoo

time25 minutes ago

  • Yahoo

Poland cancels acquisition process for 32 Black Hawk helicopters

WARSAW (Reuters) - Poland has cancelled the procurement procedure for the purchase of 32 more Lockheed Martin S-70i Black Hawk helicopters for the Polish Army, the Polish Armament Agency said on Friday. "Maybe it is necessary to acquire other equipment in its (helicopters') place such as drones, or tanks, or some kind of communication," agency spokesman Grzegorz Polak told Reuters. Polak added that "some correction" was needed when the geopolitical situation and state security interests required other tasks to be carried out. Poland launched negotiations for the acquisition of 32 S-70i Black Hawk helicopters, produced by Lockheed Martin's Polish arm PZL Mielec, in 2023 under the previous Law and Justice (PiS) government. PiS lawmaker Mariusz Blaszczak, who was defence minister in the previous government, labelled the decision a "disgrace" in a post on X, saying it would slow down the replacement of the helicopter fleet. In August 2024 Poland signed a contract with the U.S. to buy 96 AH-64E Apache attack helicopters. Under the deal with the U.S. government the helicopters would provide new combat capabilities in terms of target engagement and reconnaissance, and will replace Poland's post-Soviet Mi-24 helicopters. Polak said the Armament Agency obtained equipment in accordance with Polish army plans, which are classified. It was not the Armament Agency that set procurement priorities, he added.

Biden book author reveals how White House staff truly felt about Karine Jean-Pierre as press secretary
Biden book author reveals how White House staff truly felt about Karine Jean-Pierre as press secretary

Fox News

time26 minutes ago

  • Fox News

Biden book author reveals how White House staff truly felt about Karine Jean-Pierre as press secretary

CHICAGO - One of the authors of the new bombshell Joe Biden book pulled back the curtain Thursday on how White House staffers truly felt about former White House Press Secretary Karine Jean-Pierre. During their book tour in Chicago, "Original Sin" authors Alex Thompson and Jake Tapper were asked about the announcement of Jean-Pierre's new book promising to shed light on the "broken White House" she worked in and that she left the Democratic Party to become an independent. "Someone just texted me before I got on stage, a former Biden person, which is, 'It is quite the ballet move to say that you're leaving the Democratic Party because they were disloyal to Joe Biden.' But that is what she's saying," Thompson told the Windy City audience Thursday at The Vic Theatre. Thompson noted that despite "mass bad reviews" within the Biden administration of Jean-Pierre's job performance as White House press secretary, she was seen as "untouchable" due to her allyship with top Jill Biden aide Anthony Bernal. "I think what's really provoking anger from former Biden people… there was mass frustration on how she went about the job, felt that she was not good at it, was not aware she was not good at it, she did not try hard to get better at it. And there's more focus on elevating her own profile than not," Thompson said. "And now for her to then go out after the Democratic Party elevated her to the top spokesperson job in the country and then for her to then try to sell books by leaving the party, they say that simmering resentment just exploded instantly," the Axios reporter added. Tapper speculated that there would have been less "scorn" aimed at Jean-Pierre if she didn't announce she had become an independent, something the CNN anchor made little sense to him. The event moderator, NPR media correspondent David Folkenflik, asked Tapper and Thompson why former Biden staffers by and large "aren't using their names" as they criticize Jean-Pierre. "I totally wonder that too," Tapper reacted. "Because, like, what are you afraid of?" Thompson responded by insisting many of them don't want to speak publicly because they have since landed new jobs and don't want their employers to be associated with the mudslinging. "I'd also say that the Biden culture was to punish and try to destroy people who spoke out," Thompson said. "And yes, they don't have power anymore, but they are watching very closely. I think some people still fear retaliation." Tapper added that since Jean-Pierre was a trailblazer" as the first Black woman and LGBTQ press secretary, that was another reason why her former colleagues aren't speaking out. Both authors took turns scrutinizing Jean-Pierre's credibility following her loyal defense of Biden before and after his disastrous debate performance. Tapper recalled a 2023 private fundraiser Biden attended in which he didn't have a teleprompter and how he told donors his canned remarks about how the events of Charlottesville inspired his presidential run in 2020 twice in the span of a few minutes, and how at the following press briefing, Jean-Pierre told reporters, "Well, that's how strongly he feels about that moment." "In her defense, she rarely saw him," Tapper quipped.

United Health Products Provides Regulatory Application Update
United Health Products Provides Regulatory Application Update

Associated Press

time31 minutes ago

  • Associated Press

United Health Products Provides Regulatory Application Update

MT. LAUREL, NJ - June 6, 2025 ( NEWMEDIAWIRE ) - United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA's Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of 27 patients undergoing organ space procedures found no deficiencies but stated that the company must address the findings set forth in the assessment of the Bioresearch Monitoring (BIMO) audit of its initial 2019 clinical study. The assessment was issued by the Division of Clinical Policy and Quality on March 24, 2025, and the company submitted its detailed response addressing all findings on April 14. As of the current date, the FDA states that its review of the company's response is ongoing. Pending the resolution of the BIMO Audit assessment, the company has completed all study tasks that can be accomplished prior to the IDE approval so that patient enrollment can begin as soon as possible thereafter. About United Health Products -- UHP has developed and patented a Neutralized Regenerated Cellulose hemostatic agent. CelluSTAT Hemostatic Gauze is an all-natural product designed to control mild to moderate bleeding. UHP is seeking approval to access the human surgical market. For more information on UHP visit the company's new website: or contact the company at [email protected]. The company can also be reached by phone or text message at 475.755.1005. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words 'believes,' 'expects,' 'anticipates' or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. View the original release on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store